£5.6M
Orbit Discovery secures £5.6m in seed funding led by Oxford Sciences Innovation to accelerate growth
The financing round was led by Oxford Sciences Innovation to support the company in expanding its peptide discovery operations.
Orbit Discovery develops proprietary screening platforms for candidate peptide therapeutics.
Orbit Discovery is a biopharmaceutical business that develops proprietary screening platforms for candidate peptide therapeutics. The company uses bead-based and microfluidic technologies to identify active molecules for biotechnology and pharmaceutical partners.

Neil Butt
Chief Executive Officer
Neil serves as chief executive officer at Orbit Discovery and advises private equity. He previously held business development and executive roles across the life sciences and consulting sectors.
LinkedInGraham Ogg
Founder
Terry Rabbitts
Founder
The financing round was led by Oxford Sciences Innovation to support the company in expanding its peptide discovery operations.